Inflammation and insulin resistance
Steven E. Shoelson · Journal of Clinical Investigation · 2006
Over a hundred years ago, high doses of salicylates were shown to lower glucose levels in diabetic patients. This should have been an important clue to link inflammation to the pathogenesis of type 2 diabetes (T2D), but the antihyperglycemic and antiinflammatory effects of salicylates were not connected to the pathogenesis of insulin resistance until recently. Together with the discovery of an important role for tissue macrophages, these new findings are helping to reshape thinking about how obesity increases the risk for developing T2D and the metabolic syndrome. The evolving concept of insulin resistance and T2D as having immunological components and an improving picture of how inflammation modulates metabolism provide new opportunities for using antiinflammatory strategies to correct the metabolic consequences of excess adiposity.
Cited by 4,672 works. doi:10.1172/jci29069 Open-access PDF
Authors
References
- Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
- Positional cloning of the mouse obese gene and its human homologue
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
- Obesity is associated with macrophage accumulation in adipose tissue
- Pathogen Recognition and Innate Immunity
- A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
- The hormone resistin links obesity to diabetes
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
- Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.